Truist Securities Maintains Buy on Ovintiv, Raises Price Target to $72

Benzinga Newsdesk www.benzinga.com Positive 76.8%

Neg 0% Neu 0% Pos 76.8%

Truist Securities analyst Gabe Daoud maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $70 to $72.